Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Cureus|July 29, 2024
Exploring the Clinical Impact of RANK Pathway Inhibition in Advanced Breast Cancer: Insights From a Retrospective Study on CDK4/6 Inhibitors and Antiresorptive TherapyGoncagul Akdag, Akif Dogan, Sedat Yildirim, et al.
Medicina (Kaunas, Lithuania)|March 27, 2025
Efficacy and Clinical Outcomes of Crizotinib in Patients with ROS1-Rearranged NSCLC: A Multicenter StudyAlper Topal, Goncagul Akdag, Sedat Yildirim, et al.
Medicina (Kaunas, Lithuania)|August 29, 2024
Prognostic Impact and Clinical Features of Spread through Air Spaces in Operated Lung Cancer: Real-World AnalysisSedat Yildirim, Ozkan Alan, Zeynep Yuksel Yasar, et al.
Cancers|July 27, 2024
A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC PatientsSedat Yildirim, Akif Dogan, Goncagul Akdag, et al.
Breast Cancer Research and Treatment|April 11, 2025
Comparison of paclitaxel and docetaxel in dual HER2 blockade: efficacy and safety in neoadjuvant treatment of HER2-positive breast cancerEzgi Turkoglu, Goncagul Akdag Topal, Sedat Yildirim, et al.
Chemotherapy|February 18, 2024
Neoadjuvant Chemotherapy and Pathologic Complete Response in HR+/HER2- Breast Cancer: Impact of Tumor Ki67 and ER StatusGoncagul Akdag, Sedat Yildirim, Akif Dogan, et al.
Scientific Reports|May 27, 2024
The role of laboratory indices on treatment response and survival in breast cancer receiving neoadjuvant chemotherapySedat Yildirim, Akif Dogan, Goncagul Akdag, et al.
Scientific Reports|November 30, 2024
Bevacizumab versus aflibercept with FOLFIRI after FOLFOX and bevacizumab in RAS mutant metastatic colon cancer a Turkish oncology group studySerhat Sekmek, Sema Nur Ozsan Çelebi, Dogan Bayram, et al.
Clinical Medicine Insights. Oncology|May 14, 2026
Prognostic Impact and Clinicopathological Correlates of HER2 Status in Gastric Cancer: A Multicenter Retrospective Turkish Oncology Group StudySedat Yildirim, Ozlem Nuray Sever, Ezgi Turkoglu, et al.
Journal of Clinical Medicine|January 28, 2026
Prognostic Significance of C-PLAN Index in Patients Treated with Immunotherapy for Non-Small-Cell Lung CancerAyse Nuransoy Cengiz, Oktay Bozkurt, Muhammet Cengiz, et al.
Pageof 10